论文信息 - CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo - 字舞流文

CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo

T. Höfer | H. Hanenberg | A. Dahl | D. Lindemann | Erika E. Kuchen | N. Mende | C. Waskow | F. Calegari | T. Grinenko | Konstantinos D. Kokkaliaris | M. Lesche | Alexander Platz | Claudia Waskow